27% profit every 20 days?
This is what Nic Chahine averages with his option buys. Not selling covered calls or spreads… BUYING options. Most traders don’t even have a winning percentage of 27% buying options. He has an 83% win rate. Here’s how he does it.
- The stock price of Forward Pharma A/S (NASDAQ:FWP) fell by almost 20% during the premarket.
- Investors are responding negatively to the Technical Board of Appeal (TBA) of the European Patent Office (EPO), dismissing Forward’s appeal to revoke the EP2801355 patent (355 patent) following the oral hearing.
- The TBA had made its decision after considering Forward’s appeal against the decision of the Opposition Division and third-party submissions from several opponents.
- TBA will issue detailed reasons for the decision in written form in due course, and following receipt and review of the details, Forward will announce plans for the Company.
- Such a plan may involve a petition for review at the Enlarged Board of Appeal of the EPO to overturn the unfavorable outcome.
- But the chances of a petition for review being successful is low.
- Price Action: FWP shares are down 19.1% at $6.39 during the premarket session on the last check Tuesday.
27% profit every 20 days?
This is what Nic Chahine averages with his option buys. Not selling covered calls or spreads… BUYING options. Most traders don’t even have a winning percentage of 27% buying options. He has an 83% win rate. Here’s how he does it.
ENTER TO WIN $500 IN STOCK OR CRYPTO
Enter your email and you'll also get Benzinga's ultimate morning update AND a free $30 gift card and more!